DexCom. has been granted a patent for a wearable continuous blood glucose monitoring system. The method involves a smartwatch receiving glucose state alerts, detecting user actions to generate a glance view, and presenting glucose information, with the option to transfer this data to another device. GlobalData’s report on DexCom gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights DexCom Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on DexCom, Medical data analysis was a key innovation area identified from patents. DexCom's grant share as of July 2024 was 44%. Grant share is based on the ratio of number of grants to total number of patents.

Wearable continuous blood glucose monitoring system for smartwatches

Source: United States Patent and Trademark Office (USPTO). Credit: DexCom Inc

The patent US12073075B2 outlines a method for managing glucose state alerts through a smartwatch. The process begins with the smartwatch receiving an alert that indicates a glucose state of a host-patient, which may include a glucose value or a rate of change that meets specific criteria. In response to this alert, the smartwatch detects a predetermined action, such as a physical button press or specific wrist movement, which prompts the device to generate a glance view of glucose information. The smartwatch then selects an appropriate view from multiple options based on the glucose state and presents this information as a glance view. Additionally, the smartwatch can hand off this glance view to another device, such as a smartphone or tablet, to display more detailed content.

The patent further details various features of the method, including the use of low-power radio access transceivers for alert reception, which may utilize technologies like Bluetooth or NFC. The smartwatch can also provide feedback through haptic, audio, or visual indicators upon detecting the predetermined action. The glance view can be customized based on the user's role or specific glucose states, and it may include a notification bar with actionable selections. The method allows for the reception of multiple alerts, enabling the smartwatch to present different glance views as needed. Overall, this patent presents a comprehensive approach to monitoring and displaying glucose information in a user-friendly manner through smart wearable technology.

To know more about GlobalData’s detailed insights on DexCom, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.